Mizuho analyst John Roberts raised the firm’s price target on Chemours (CC) to $19 from $16 and keeps an Outperform rating on the shares. The firm recommends the stock, saying per- and polyfluoroalkyl substance settlements “are trending in the right direction.” It cites higher market multiples for the target increase.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC: